My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 150

    1.

    Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity.

    Bertola A, Deveaux V, Bonnafous S, Rousseau D, Anty R, Wakkach A, Dahman M, Tordjman J, Clément K, McQuaid SE, Frayn KN, Huet PM, Gugenheim J, Lotersztajn S, Le Marchand-Brustel Y, Tran A, Gual P.

    Diabetes. 2009 Jan;58(1):125-33. Epub 2008 Oct 24.PMID: 18952835 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations.

    Kiefer FW, Zeyda M, Todoric J, Huber J, Geyeregger R, Weichhart T, Aszmann O, Ludvik B, Silberhumer GR, Prager G, Stulnig TM.

    Endocrinology. 2008 Mar;149(3):1350-7. Epub 2007 Nov 29.PMID: 18048491 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.

    Alessi MC, Bastelica D, Mavri A, Morange P, Berthet B, Grino M, Juhan-Vague I.

    Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1262-8. Epub 2003 May 15.PMID: 12750120 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.

    Liu LF, Purushotham A, Wendel AA, Belury MA.

    Am J Physiol Gastrointest Liver Physiol. 2007 Jun;292(6):G1671-82. Epub 2007 Feb 22.PMID: 17322064 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.

    Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M.

    J Clin Invest. 2006 Jun;116(6):1494-505. Epub 2006 May 11.PMID: 16691291 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Plasma osteopontin levels and expression in adipose tissue are increased in obesity.

    Gómez-Ambrosi J, Catalán V, Ramírez B, Rodríguez A, Colina I, Silva C, Rotellar F, Mugueta C, Gil MJ, Cienfuegos JA, Salvador J, Frühbeck G.

    J Clin Endocrinol Metab. 2007 Sep;92(9):3719-27. Epub 2007 Jun 26.PMID: 17595250 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice.

    Yu R, Kim CS, Kwon BS, Kawada T.

    Obesity (Silver Spring). 2006 Aug;14(8):1353-62.PMID: 16988077 [PubMed - indexed for MEDLINE]Related articles

    8.

    Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.

    Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF.

    Am J Physiol Gastrointest Liver Physiol. 2004 Jul;287(1):G264-73. Epub 2004 Mar 25.PMID: 15044174 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH.

    Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben Amor I, Saint-Paul MC, Huet PM, Sadoul JL, Gugenheim J, Srai SK, Tran A, Le Marchand-Brustel Y.

    Gastroenterology. 2006 Sep;131(3):788-96.PMID: 16952548 [PubMed - indexed for MEDLINE]Related articles

    10.

    A novel aminosterol reverses diabetes and fatty liver disease in obese mice.

    Takahashi N, Qi Y, Patel HR, Ahima RS.

    J Hepatol. 2004 Sep;41(3):391-8.PMID: 15336441 [PubMed - indexed for MEDLINE]Related articles

    11.

    Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.

    Baranova A, Gowder SJ, Schlauch K, Elariny H, Collantes R, Afendy A, Ong JP, Goodman Z, Chandhoke V, Younossi ZM.

    Obes Surg. 2006 Sep;16(9):1118-25.PMID: 16989692 [PubMed - indexed for MEDLINE]Related articles

    12.

    Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance.

    Riedl M, Vila G, Maier C, Handisurya A, Shakeri-Manesch S, Prager G, Wagner O, Kautzky-Willer A, Ludvik B, Clodi M, Luger A.

    J Clin Endocrinol Metab. 2008 Jun;93(6):2307-12. Epub 2008 Mar 11.PMID: 18334587 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.

    Vidal-Puig AJ, Considine RV, Jimenez-Liñan M, Werman A, Pories WJ, Caro JF, Flier JS.

    J Clin Invest. 1997 May 15;99(10):2416-22.PMID: 9153284 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Obesity is associated with macrophage accumulation in adipose tissue.

    Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr.

    J Clin Invest. 2003 Dec;112(12):1796-808.PMID: 14679176 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice.

    Vieira VJ, Valentine RJ, Wilund KR, Antao N, Baynard T, Woods JA.

    Am J Physiol Endocrinol Metab. 2009 May;296(5):E1164-71. Epub 2009 Mar 10.PMID: 19276393 [PubMed - indexed for MEDLINE]Related articles

    16.

    Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice.

    Tamura Y, Sugimoto M, Murayama T, Ueda Y, Kanamori H, Ono K, Ariyasu H, Akamizu T, Kita T, Yokode M, Arai H.

    Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2195-201. Epub 2008 Sep 25.PMID: 18818420 [PubMed - indexed for MEDLINE]Related articles

    17.

    Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.

    Haluzik MM, Lacinova Z, Dolinkova M, Haluzikova D, Housa D, Horinek A, Vernerova Z, Kumstyrova T, Haluzik M.

    Endocrinology. 2006 Sep;147(9):4517-24. Epub 2006 Jun 1.PMID: 16740970 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice.

    Nomiyama T, Perez-Tilve D, Ogawa D, Gizard F, Zhao Y, Heywood EB, Jones KL, Kawamori R, Cassis LA, Tschöp MH, Bruemmer D.

    J Clin Invest. 2007 Oct;117(10):2877-88.PMID: 17823662 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor alpha expression following ethanol-associated hepatic injury in vivo and in vitro.

    Lee JH, Banerjee A, Ueno Y, Ramaiah SK.

    Toxicol Sci. 2008 Nov;106(1):290-9. Epub 2008 Aug 14.PMID: 18703563 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus.

    Hube F, Birgel M, Lee YM, Hauner H.

    Eur J Clin Invest. 1999 Aug;29(8):672-8.PMID: 10457150 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity